NCT05140161 is a NA clinical trial of collagen in Nails, Ingrown, sponsored by University of Seville.

Who is sponsoring NCT05140161?

NCT05140161 is sponsored by University of Seville.

What drugs are being tested in NCT05140161?

Interventions in NCT05140161: collagen.

What condition does NCT05140161 study?

NCT05140161 studies Nails, Ingrown, Coagulation Defect; Bleeding.

Is NCT05140161 still recruiting?

NCT05140161 is currently status unknown. Last updated 1 December 2021.

Last reviewed 2021-12-01 · How we verify

NCT05140161

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Hemostasis Assesment After Application of Lyophilisate Collagen in Nail Surgery

Status unknown NA Last updated 1 December 2021

What this trial tests

NA trial testing collagen in Nails, Ingrown in 98 participants. Status unknown.

Timeline

20 December 2021

Primary endpoint
29 December 2021

21 February 2022

Quick facts

Lead sponsor	University of Seville
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	treatment
Enrollment	98
Start date	20 December 2021
Primary completion	29 December 2021
Estimated completion	21 February 2022

Drugs / interventions tested

collagen

Conditions studied

Nails, Ingrown — all drugs for Nails, Ingrown →
Coagulation Defect; Bleeding — all drugs for Coagulation Defect; Bleeding →

Sponsor

University of Seville

Who can join

Adults 15 to 70, any sex, with Nails, Ingrown or Coagulation Defect; Bleeding. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of this study is to evaluate the hemostatic capacity of two types of collagen hemostatic sponges in nail surgery. It is a randomized triple-blind clinical trial with two experimental groups (medium porosity collagen and high porosity collagen) and control group ( non collagen).

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Hemostatic Efficacy of Absorbable Gelatin Sponges for Surgical Nail Matrixectomy after Phenolization-A Blinded Randomized Controlled Trial.
Córdoba-Fernández A, Lobo-Martín A. · · 2022 · cited 3× · PMID 35566545 · DOI 10.3390/jcm11092420

Verify or expand the search:

Other University of Seville trials

Trials by the same sponsor.

NCT07501273 — Analgesic Effect of a Biophotonic Foot Massage Cream · NA · not yet recruiting
NCT07387627 — Effectiveness of the COPCA Program in Infants at Risk of Neurodevelopmental Disorders · NA · not yet recruiting
NCT07361887 — Deciphering the Effect of Moderate Wine Consumption on Healthy Aging Through Postprandial Extracellular Vesicles. · NA · recruiting
NCT06978582 — Effectiveness and Safety of a Tele-Rehabilitation Program on Fatigue and Related Variables in Chronic Fatigue Syndrome a · NA · active not recruiting
NCT07208045 — Cultural Adaptation, Validation, and Evaluation of the Programme for Promotion of Healthy Affective-Sexual Behaviours in · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05140161 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Seville
Last refreshed: 1 December 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05140161.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing